Filing Details
- Accession Number:
- 0001567619-21-011167
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-25 18:44:42
- Reporting Period:
- 2021-05-21
- Accepted Time:
- 2021-05-25 18:44:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1080014 | Innoviva Inc. | INVA | Pharmaceutical Preparations (2834) | 943265960 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1329646 | George Bickerstaff | 1350 Old Bayshore Highway, Suite 400 Burlingame CA 94010 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-21 | 10,000 | $12.97 | 114,560 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-05-24 | 10,000 | $13.46 | 124,560 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.9650 to $12.9670, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.24 to $13.54, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.